Colorectal and Peritoneal Oncology Annual Service Report 2021 - 2022

Service Report 2022 Colorectal and Peritoneal Oncology Centre – The Christie NHS Foundation Trust treating obese patients: the OCT OPUS consortium”. (Oral) (C Slawinski, L Malcomson, H Guo, J Barriuso, A Harkin, T Iveson, R Glynne-Jones, C van de Velde, A Renehan)

• International Multidisciplinary Anal Cancer Conference – IMACC 2021 2021

o “ CORMAC-2: International consensus to define outcomes for trials of chemoratiotherapy for anal cancer (CORMAC-2): Defining the outcomes from the CORMAC core outcome set ” (Oral and Poster) (Samuel R, Sebag-Montefiore D, Adams R, Hawkins M, Williamson P, Das P, Dorth J, Guren M, Renehan A , Fish R)

Manchester Medical Society 2021

•

o “Radiological patterns and timing of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with Colorectal Cancer Peritoneal Me tastases”. (Oral) (S Hassan, Y J Soh, O Aziz, H Clouston, J Wild, C Selvasekar, M S Wilson, S O’Dwyer, A G Renehan, R Kochhar) o “Peritoneal recurrence following appendicectomy for perforated low -grade mucinous appendiceal neoplasms: evaluation of a dual strategy of watch-and-wait and risk-reducing cytoreductive surgery and heated intraperitoneal chemotherapy”. (Oral) (B Aljalabneh, J Wild) • Knowledge Asset Grant (2022), The feasibility of creating combined genetic, clinical and quality of life datasets in patients with locally recurrent rectal cancer (P Sutton, O Aziz, S O’Dwyer, Award value £24,000) • Manchester Academic Health Science Centre (MAHSC) (2021-2022), Development of a ‘prehabilitation’ App to improve patient post -operative outcomes. (O Aziz, J Saxton & J Allen, Award value £24,000) • Pseudomyxoma Survivor charity (2022-2023), Development of a ‘prehabilitation’ App to improve patient post-operative outcomes. (O Aziz, J Saxton & J Allen, Award value £22,000) • European Organisation for Research and Treatment of Cancer (2021-2024), EORTC QLG new module development- neoadjuvant treatment in rectal cancer (A Gilbert & R Fish, Award value 122,751 Euros) • European Society for Medical Oncology (2021-2024), Genomics of appendix adenocarcinoma (J Barriuso & O Aziz, Award value 40,000 Euros) • Marie- Skłodowska Curie ITN Early Stage Researcher (2020 -2023), ValCoRe: Value of Benefit from a new cancer treatment: clinical complete response in rectal cancer (A Renehan, Award value £211,202) • CRUK Accelerator Award (2020-2025), Pseudomyxoma peritonei: building a European multicentric cohort to accelerate new therapeutic perspectives (S O’Dwyer, J Barriuso &O Aziz, Award value £2.5m) • Christie Charity (2020- 2025), Colorectal and Peritoneal Oncology Academy (S O’Dwyer & O Aziz, Award value £375,000) • NIHR (2019-2022), Cytoreductive surgery with hyperthermic intraoperative peritoneal chemotherapy versus standard of care in people with peritoneal metastases from colorectal, ovarian or gastric origin:

5.5 Grants

21